Molecular techniques and genetic alterations in head and neck cancer

Oral Oncology

Volumn 45, Issue 4-5, 2009, Pages 335-339

  Ha, Patrick K ^a,b   Chang, Steven S ^a   Glazer, Chad A ^a   Califano, Joseph A ^a,b   Sidransky, David ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b GREATER BALTIMORE MEDICAL CENTER   (United States)

Author keywords

DNA; Head and neck cancer; Molecular; Oral cancer

Indexed keywords

CELL DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; MATRIX METALLOPROTEINASE; MICRORNA; STRESS ACTIVATED PROTEIN KINASE;

CANCER RESEARCH; CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CHROMOSOME ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; DNA HYBRIDIZATION; DNA MICROARRAY; DNA SEQUENCE; GENE EXPRESSION; GENE IDENTIFICATION; GENE MUTATION; GENE SILENCING; GENOME; GENOTYPE; HEAD AND NECK CANCER; HETEROZYGOSITY LOSS; HUMAN; MITOCHONDRION; MOLECULAR BIOLOGY; MOLECULAR GENETICS; ONCOGENE; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SPECTRAL KARYOTYPING; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

CARCINOMA, SQUAMOUS CELL; CYTOGENETIC ANALYSIS; GENE EXPRESSION PROFILING; GENES, TUMOR SUPPRESSOR; HEAD AND NECK NEOPLASMS; HUMANS; LOSS OF HETEROZYGOSITY; MITOCHONDRIA; MOLECULAR BIOLOGY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENES; RESEARCH;

EID: 67349182113     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2008.05.015     Document Type: Review

References (74)

1. Jin C., Jin Y., Wennerberg J., Annertz K., Enoksson J., and Mertens F. Cytogenetic abnormalities in 106 oral squamous cell carcinomas. Cancer Genet Cytogenet 164 1 (2006) 44-53
2. Patmore H.S., Ashman J.N., Stafford N.D., Berrieman H.K., MacDonald A., Greenman J., et al. Genetic analysis of head and neck squamous cell carcinoma using comparative genomic hybridisation identifies specific aberrations associated with laryngeal origin. Cancer Lett 258 1 (2007) 55-62
3. Singh B., Gogineni S., Goberdhan A., Sacks P., Shaha A., Shah J., et al. Spectral karyotyping analysis of head and neck squamous cell carcinoma. Laryngoscope 111 9 (2001) 1545-1550
4. Singh B., Gogineni S.K., Sacks P.G., Shaha A.R., Shah J.P., Stoffel A., et al. Molecular cytogenetic characterization of head and neck squamous cell carcinoma and refinement of 3q amplification. Cancer Res 61 11 (2001) 4506-4513
5. Uchida K., Oga A., Okafuji M., Mihara M., Kawauchi S., Furuya T., et al. Molecular cytogenetic analysis of oral squamous cell carcinomas by comparative genomic hybridization, spectral karyotyping, and fluorescence in situ hybridization. Cancer Genet Cytogenet 167 2 (2006) 109-116
6. Hirshberg A., Yarom N., Amariglio N., Yahalom R., Adam I., Stanchescu R., et al. Detection of non-diploid cells in premalignant and malignant oral lesions using combined morphological and FISH analysis - a new method for early detection of suspicious oral lesions. Cancer Lett 253 2 (2007) 282-290
7. An J., Liu Z., Hu Z., Li G., Wang L.E., Sturgis E.M., et al. Potentially functional single nucleotide polymorphisms in the core nucleotide excision repair genes and risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev 16 8 (2007) 1633-1638
8. Li C., Hu Z., Lu J., Liu Z., Wang L.E., El-Naggar A.K., et al. Genetic polymorphisms in DNA base-excision repair genes ADPRT, XRCC1, and APE1 and the risk of squamous cell carcinoma of the head and neck. Cancer 110 4 (2007) 867-875
9. Majumder M., Sikdar N., Ghosh S., and Roy B. Polymorphisms at XPD and XRCC1 DNA repair loci and increased risk of oral leukoplakia and cancer among NAT2 slow acetylators. Int J Cancer 120 10 (2007) 2148-2156
10. Wang Y., Spitz M.R., Lee J.J., Huang M., Lippman S.M., and Wu X. Nucleotide excision repair pathway genes and oral premalignant lesions. Clin Cancer Res 13 12 (2007) 3753-3758
11. Anantharaman D., Chaubal P.M., Kannan S., Bhisey R.A., and Mahimkar M.B. Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator. Carcinogenesis 28 7 (2007) 1455-1462
12. Datta S., Majumder M., Biswas N.K., Sikdar N., and Roy B. Increased risk of oral cancer in relation to common Indian mitochondrial polymorphisms and Autosomal GSTP1 locus. Cancer 110 9 (2007) 1991-1999
13. Li D., Wang L.E., Chang P., El-Naggar A.K., Sturgis E.M., and Wei Q. In vitro benzo[a]pyrene diol epoxide-induced DNA adducts and risk of squamous cell carcinoma of head and neck. Cancer Res 67 12 (2007) 5628-5634
14. Singh M., Shah P.P., Singh A.P., Ruwali M., Mathur N., Pant M.C., et al. Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer. Mutat Res 638 1-2 (2008) 184-194
15. Suzen H.S., Guvenc G., Turanli M., Comert E., Duydu Y., and Elhan A. The role of GSTM1 and GSTT1 polymorphisms in head and neck cancer risk. Oncol Res 16 9 (2007) 423-429
16. Kuroda Y., Nakao H., Ikemura K., and Katoh T. Association between the TP53 codon72 polymorphism and oral cancer risk and prognosis. Oral Oncol 43 10 (2007) 1043-1048
17. Califano J., van der Riet P., Westra W., Nawroz H., Clayman G., Piantadosi S., et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 56 11 (1996) 2488-2492
18. Baldwin C., Garnis C., Zhang L., Rosin M.P., and Lam W.L. Multiple microalterations detected at high frequency in oral cancer. Cancer Res 65 17 (2005) 7561-7567
19. Sparano A., Quesnelle K.M., Kumar M.S., Wang Y., Sylvester A.J., Feldman M., et al. Genome-wide profiling of oral squamous cell carcinoma by array-based comparative genomic hybridization. Laryngoscope 116 5 (2006) 735-741
20. Garnis C., Coe B.P., Zhang L., Rosin M.P., and Lam W.L. Overexpression of LRP12, a gene contained within an 8q22 amplicon identified by high-resolution array CGH analysis of oral squamous cell carcinomas. Oncogene 23 14 (2004) 2582-2586
21. Tong B.C., Dhir K., Ha P.K., Westra W.H., Alter B.P., Sidransky D., et al. Use of single nucleotide polymorphism arrays to identify a novel region of loss on chromosome 6q in squamous cell carcinomas of the oral cavity. Head Neck 26 4 (2004) 345-352
22. van den Broek G.B., Wreesmann V.B., van den Brekel M.W., Rasch C.R., Balm A.J., and Rao P.H. Genetic abnormalities associated with chemoradiation resistance of head and neck squamous cell carcinoma. Clin Cancer Res 13 15 Pt 1 (2007) 4386-4391
23. Gottschlich S., Ambrosch P., Cordes C., Gorogh T., Schreiber S., and Hasler R. Gene expression profiling of head and neck squamous cell carcinoma using cDNA microarrays. Int J Oncol 29 3 (2006) 605-613
24. Whipple M.E., Mendez E., Farwell D.G., Agoff S.N., and Chen C. A genomic predictor of oral squamous cell carcinoma. Laryngoscope 114 8 (2004) 1346-1354
25. Ha P.K., Benoit N.E., Yochem R., Sciubba J., Zahurak M., Sidransky D., et al. A transcriptional progression model for head and neck cancer. Clin Cancer Res 9 8 (2003) 3058-3064
26. Carinci F., Arcelli D., Lo Muzio L., Francioso F., Valentini D., Evangelisti R., et al. Molecular classification of nodal metastasis in primary larynx squamous cell carcinoma. Trans Res 150 4 (2007) 233-245
27. Mendez E., Fan W., Choi P., Agoff S.N., Whipple M., Farwell D.G., et al. Tumor-specific genetic expression profile of metastatic oral squamous cell carcinoma. Head Neck 29 9 (2007) 803-814
28. Ganly I., Talbot S., Carlson D., Viale A., Maghami E., Osman I., et al. Identification of angiogenesis/metastases genes predicting chemoradiotherapy response in patients with laryngopharyngeal carcinoma. J Clin Oncol 25 11 (2007) 1369-1376
29. Ishigami T., Uzawa K., Higo M., Nomura H., Saito K., Kato Y., et al. Genes and molecular pathways related to radioresistance of oral squamous cell carcinoma cells. Int J Cancer 120 10 (2007) 2262-2270
30. Winter S.C., Buffa F.M., Silva P., Miller C., Valentine H.R., Turley H., et al. Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers. Cancer Res 67 7 (2007) 3441-3449
31. Olivier M., Eeles R., Hollstein M., Khan M.A., Harris C.C., and Hainaut P. The IARC TP53 database: news online mutation analysis and recommendations to users. Hum Mutat 19 6 (2002) 607-614
32. Sherr C.J. Principles of tumor suppression. Cell 116 2 (2004) 235-246
33. Boyle J.O., Hakim J., Koch W., van der Riet P., Hruban R.H., Roa R.A., et al. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res 53 19 (1993) 4477-4480
34. Somers K.D., Merrick M.A., Lopez M.E., Incognito L.S., Schechter G.L., and Casey G. Frequent p53 mutations in head and neck cancer. Cancer Res 52 21 (1992) 5997-6000
35. Ku T.K., Nguyen D.C., Karaman M., Gill P., Hacia J.G., and Crowe D.L. Loss of p53 expression correlates with metastatic phenotype and transcriptional profile in a new mouse model of head and neck cancer. Mol Cancer Res 5 4 (2007) 351-362
36. Poeta M.L., Manola J., Goldwasser M.A., Forastiere A., Benoit N., Califano J.A., et al. TP53 mutations and survival in squamous-cell carcinoma of the head and neck. New Engl J Med 357 25 (2007) 2552-2561
37. Valentin-Vega Y.A., Barboza J.A., Chau G.P., El-Naggar A.K., and Lozano G. High levels of the p53 inhibitor MDM4 in head and neck squamous carcinomas. Hum Pathol 38 10 (2007) 1553-1562
38. Bradford C.R., Zhu S., Ogawa H., Ogawa T., Ubell M., Narayan A., et al. P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines. Head Neck 25 8 (2003) 654-661
39. Cabelguenne A., Blons H., de Waziers I., Carnot F., Houllier A.M., Soussi T., et al. p53 alterations predict tumor response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma: a prospective series. J Clin Oncol 18 7 (2000) 1465-1473
40. Koch W.M., Brennan J.A., Zahurak M., Goodman S.N., Westra W.H., Schwab D., et al. p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma. J Nat Cancer Inst 88 21 (1996) 1580-1586
41. Mineta H., Borg A., Dictor M., Wahlberg P., Akervall J., and Wennerberg J. p53 mutation, but not p53 overexpression, correlates with survival in head and neck squamous cell carcinoma. Br J Cancer 78 8 (1998) 1084-1090
42. Temam S., Flahault A., Perie S., Monceaux G., Coulet F., Callard P., et al. p53 gene status as a predictor of tumor response to induction chemotherapy of patients with locoregionally advanced squamous cell carcinomas of the head and neck. J Clin Oncol 18 2 (2000) 385-394
43. Friedman J., Nottingham L., Duggal P., Pernas F.G., Yan B., Yang X.P., et al. Deficient TP53 expression, function, and cisplatin sensitivity are restored by quinacrine in head and neck cancer. Clin Cancer Res 13 22 Pt 1 (2007) 6568-6578
44. Ai L., Stephenson K.K., Ling W., Zuo C., Mukunyadzi P., Suen J.Y., et al. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases. Mod Pathol 16 9 (2003) 944-950
45. Reed A.L., Califano J., Cairns P., Westra W.H., Jones R.M., Koch W., et al. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res 56 16 (1996) 3630-3633
46. Carvalho A.L., Chuang A., Jiang W.W., Lee J., Begum S., Poeta L., et al. Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma. Cancer Res 66 19 (2006) 9401-9407
47. Venugopalan M., Wood T.F., Wilczynski S.P., Sen S., Peters J., Ma G.C., et al. Loss of heterozygosity in squamous cell carcinomas of the head and neck defines a tumor suppressor gene region on 11q13. Cancer Genet Cytogenet 104 2 (1998) 124-132
48. Nakaya K., Yamagata H.D., Arita N., Nakashiro K.I., Nose M., Miki T., et al. Identification of homozygous deletions of tumor suppressor gene FAT in oral cancer using CGH-array. Oncogene 26 36 (2007) 5300-5308
49. Paz-Elizur T., Ben-Yosef R., Elinger D., Vexler A., Krupsky M., Berrebi A., et al. Reduced repair of the oxidative 8-oxoguanine DNA damage and risk of head and neck cancer. Cancer Res 66 24 (2006) 11683-11689
50. Ishitoya J., Toriyama M., Oguchi N., Kitamura K., Ohshima M., Asano K., et al. Gene amplification and overexpression of EGF receptor in squamous cell carcinomas of the head and neck. Br J Cancer 59 4 (1989) 559-562
51. Rubin Grandis J., Melhem M.F., Gooding W.E., Day R., Holst V.A., Wagener M.M., et al. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival. J Nat Cancer Inst 90 11 (1998) 824-832
52. Hibi K., Trink B., Patturajan M., Westra W.H., Caballero O.L., Hill D.E., et al. AIS is an oncogene amplified in squamous cell carcinoma. Proc Nat Acad Sci USA 97 10 (2000) 5462-5467
53. Rocco J.W., Leong C.O., Kuperwasser N., DeYoung M.P., and Ellisen L.W. p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis. Cancer Cell 9 1 (2006) 45-56
54. Vairaktaris E., Serefoglou Z., Yapijakis C., Vylliotis A., Nkenke E., Derka S., et al. High gene expression of matrix metalloproteinase-7 is associated with early stages of oral cancer. Anticancer Res 27 4B (2007) 2493-2498
55. Kusukawa J., Sasaguri Y., Shima I., Kameyama T., and Morimatsu M. Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinoma A clinicopathologic study. Am J Clin Pathol 99 1 (1993) 18-23
56. P O.C., Rhys-Evans P.H., and Eccles S.A. Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 127 7 (2001) 813-820
57. Franchi A., Santucci M., Masini E., Sardi I., Paglierani M., and Gallo O. Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck. Cancer 95 9 (2002) 1902-1910
58. Liu S.Y., Liu Y.C., Huang W.T., Huang G.C., Su H.J., and Lin M.H. Requirement of MMP-3 in anchorage-independent growth of oral squamous cell carcinomas. J Oral Pathol Med 36 7 (2007) 430-435
59. Gibcus J.H., Menkema L., Mastik M.F., Hermsen M.A., de Bock G.H., van Velthuysen M.L., et al. Amplicon mapping and expression profiling identify the Fas-associated death domain gene as a new driver in the 11q13. 3 amplicon in laryngeal/pharyngeal cancer. Clin Cancer Res 13 21 (2007) 6257-6266
60. Gross N.D., Boyle J.O., Du B., Kekatpure V.D., Lantowski A., Thaler H.T., et al. Inhibition of Jun NH2-terminal kinases suppresses the growth of experimental head and neck squamous cell carcinoma. Clin Cancer Res 13 19 (2007) 5910-5917
61. Shimizu S., Seki N., Sugimoto T., Horiguchi S., Tanzawa H., Hanazawa T., et al. Identification of molecular targets in head and neck squamous cell carcinomas based on genome-wide gene expression profiling. Oncol Rep 18 6 (2007) 1489-1497
62. Kim M.M., Clinger J.D., Masayesva B.G., Ha P.K., Zahurak M.L., Westra W.H., et al. Mitochondrial DNA quantity increases with histopathologic grade in premalignant and malignant head and neck lesions. Clin Cancer Res 10 24 (2004) 8512-8515
63. Shidara Y., Yamagata K., Kanamori T., Nakano K., Kwong J.Q., Manfredi G., et al. Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis. Cancer Res 65 5 (2005) 1655-1663
64. Selak M.A., Armour S.M., MacKenzie E.D., Boulahbel H., Watson D.G., Mansfield K.D., et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 7 1 (2005) 77-85
65. Zhou S., Kachhap S., Sun W., Wu G., Chuang A., Poeta L., et al. Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neck. Proc Nat Acad Sci USA 104 18 (2007) 7540-7545
66. He Q.Y., Chen J., Kung H.F., Yuen A.P., and Chiu J.F. Identification of tumor-associated proteins in oral tongue squamous cell carcinoma by proteomics. Proteomics 4 1 (2004) 271-278
67. Koike H., Uzawa K., Nakashima D., Shimada K., Kato Y., Higo M., et al. Identification of differentially expressed proteins in oral squamous cell carcinoma using a global proteomic approach. Int J Oncol 27 1 (2005) 59-67
68. Roesch-Ely M., Nees M., Karsai S., Ruess A., Bogumil R., Warnken U., et al. Proteomic analysis reveals successive aberrations in protein expression from healthy mucosa to invasive head and neck cancer. Oncogene 26 1 (2007) 54-64
69. Sewell D.A., Yuan C.X., and Robertson E. Proteomic signatures in laryngeal squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec 69 2 (2007) 77-84
70. Prince M.E., Sivanandan R., Kaczorowski A., Wolf G.T., Kaplan M.J., Dalerba P., et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Nat Acad Sci USA 104 3 (2007) 973-978
71. Lee R.C., Feinbaum R.L., and Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75 5 (1993) 843-854
72. Tran N., McLean T., Zhang X., Zhao C.J., Thomson J.M., O'Brien C., et al. MicroRNA expression profiles in head and neck cancer cell lines. Biochem Biophys Res Commun 358 1 (2007) 12-17
73. Lorch J.H., Posner M.R., Wirth L.J., and Haddad R.I. Seeking alternative biological therapies: The future of targeted molecular treatment. Oral Oncol 45 (2009) 449-455
74. Glazer C.A., Chang S.S., Ha P.K., and Califano J.A. Applying the molecular biology and epigenetics of head and neck cancer in everyday clinical practice. Oral Oncol 45 (2009) 442-448